BIOMAT Database Logo BIOMAT Database Logo

[Adrenal cortical androgen function in women suffering from sterility and hyperprolactinemia]. 1981

N M Pobedinskiĭ, and V G Orlova, and I A Pakhomova, and F K Alieva

UI MeSH Term Description Entries
D007247 Infertility, Female Diminished or absent ability of a female to achieve conception. Sterility, Female,Sterility, Postpartum,Sub-Fertility, Female,Subfertility, Female,Female Infertility,Female Sterility,Female Sub-Fertility,Female Subfertility,Postpartum Sterility,Sub Fertility, Female
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D003687 Dehydroepiandrosterone A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. Dehydroisoandrosterone,Prasterone,5-Androsten-3-beta-hydroxy-17-one,5-Androsten-3-ol-17-one,Androstenolone,DHEA,Prasterone, 3 alpha-Isomer,5 Androsten 3 beta hydroxy 17 one,5 Androsten 3 ol 17 one,Prasterone, 3 alpha Isomer
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000302 Adrenal Cortex The outer layer of the adrenal gland. It is derived from MESODERM and comprised of three zones (outer ZONA GLOMERULOSA, middle ZONA FASCICULATA, and inner ZONA RETICULARIS) with each producing various steroids preferentially, such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and ANDROSTENEDIONE. Adrenal cortex function is regulated by pituitary ADRENOCORTICOTROPIN. Cortex, Adrenal
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D015068 17-Ketosteroids Steroids that contain a ketone group at position 17. 17-Oxosteroids,17 Ketosteroids,17 Oxosteroids

Related Publications

N M Pobedinskiĭ, and V G Orlova, and I A Pakhomova, and F K Alieva
[Specialized service to women suffering from sterility].
February 1976, Akusherstvo i ginekologiia,
N M Pobedinskiĭ, and V G Orlova, and I A Pakhomova, and F K Alieva
[Hyperprolactinemia and sterility].
July 1979, Archives of gynecology,
N M Pobedinskiĭ, and V G Orlova, and I A Pakhomova, and F K Alieva
[Use of function tests in the diagnosis of hyperprolactinemia in women treated for sterility].
May 1989, Ceskoslovenska gynekologie,
N M Pobedinskiĭ, and V G Orlova, and I A Pakhomova, and F K Alieva
[Histological changes in the hypophysis, adrenal cortex and ovary in women suffering from sterility in connection with Itsenko-Cushing's syndrome].
January 1965, Problemy endokrinologii i gormonoterapii,
N M Pobedinskiĭ, and V G Orlova, and I A Pakhomova, and F K Alieva
[Hyperprolactinemia and idiopathic sterility].
August 1994, Ceska gynekologie,
N M Pobedinskiĭ, and V G Orlova, and I A Pakhomova, and F K Alieva
[Hyperprolactinemia and female sterility].
July 1979, Archives of gynecology,
N M Pobedinskiĭ, and V G Orlova, and I A Pakhomova, and F K Alieva
Lack of adrenal androgen stimulation by ACTH in extreme hyperprolactinemia.
November 1979, Archives of andrology,
N M Pobedinskiĭ, and V G Orlova, and I A Pakhomova, and F K Alieva
[Adrenal cortical steroidogenesis and adrenal androgen secretion in Cushing disease].
February 2007, Problemy endokrinologii,
N M Pobedinskiĭ, and V G Orlova, and I A Pakhomova, and F K Alieva
The genetic implications of clinical radiation of women suffering from sterility.
January 1960, Journal of the National Medical Association,
N M Pobedinskiĭ, and V G Orlova, and I A Pakhomova, and F K Alieva
[Hyperprolactinemia, secondary amenorrhea and sterility].
January 1980, Anales de la Real Academia Nacional de Medicina,
Copied contents to your clipboard!